Abstract
Efficacy of brodalumab in moderate-to-severe plaque psoriasis after failure of previous biologic therapy: A phase 4, multicenter, open-label study
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have